Saba Capital Management, L.P. bought HQL
June 5, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 26,083 shares of Abrdn Life Sciences Investors at $13.76 per share, a transaction worth $358.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
26,083
Price
$13.76
Total value
$358.9K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 5, 2024
Filing dateJune 5, 2024
Shares owned after3,380,108
OwnershipIndirect
10b5-1 planNo
AmendedNo